Chronic neuropathic pain post thoracotomy for Ivor Lewis oesphagectomy  by Elsharif, Mohamed et al.
Abstracts / International Journal of Surgery 12 (2014) S13eS117S98Conclusions: Negative laparotomies rates are reducing but slowly. It is
important for institutions such as those in rural South Africa to invest in
surgical expertise to be able to select appropriate cases for exploratory
laparotomy and therefore reduce patient morbidity and reduce hospital
costs.
Upper-gastrointestinal surgery
0018: CHRONIC NEUROPATHIC PAIN POST THORACOTOMY FOR IVOR
LEWIS OESPHAGECTOMY
Mohamed Elsharif *, Laura Lewis, Bruno Sgromo. Oxford Radcliffe Teaching
Hospitals, Oxford, UK.
Introduction: Chronic pain post thoracotomy is a well-recognised prob-
lem following oesophagectomy due to various aspects related to the in-
cisions location and may theoretically involve a neuropathic component
due to compression of intercostal nerves under the rib spreader. Reported
incidence has varied [11%-80%] with various surgical and anaesthetic
techniques being used over the years, as a tertiary referral centre which
performs 100 oesophagectomies a year we conducted this study to
establish incidence in contemporary practice and assess whether or not a
neuropathic component was involved.
Methods: Detailed phone questionnaires using PAINDETECT assessment
tool were conducted with 43 oesophagectomy patients a year following
their surgery.
Results: Incidence of chronic pain was reported at 56%, the majority of
patients had at least 1 neuropathic feature in their pain descriptors, but
only 4% fulﬁlled all criteria for neuropathic pain. Only 50% of sufferers were
receiving pain treatment of any sort.
Conclusions: Current day practice is still associated with a high incidence
of chronic pain, however only a minority of patients fulﬁl the criteria for
neuropathic pain bringing into question our assumptions about the nature
of this pain. Long-term pain management should be reviewed and audited
as a service quality indicator.
0023: OUTCOMES OF LAPAROSCOPIC FUNDOPLICATION WITH THE USE
OF BIO-MESH IN PATIENTS WITH GORD OR LARGE SYMPTOMATIC HIA-
TAL HERNIAS
Michelle Christodoulidou *, Sarah Hassan, Paul Sutton, Joseph Varghese.
Royal Bolton Hospital NHS Foundation Trust, Bolton, UK.
Introduction: Since 2011 in cases where we have identiﬁed a large hiatus
hernia during Laparoscopic fundoplication, the hiatal repair was
augmented with biosynthetic mesh (Gore Bio-A®). With this audit we
aimed to establish the impact of the addition of mesh on symptomatic
outcomes.
Methods: All Laparoscopic fundoplication's performed between October
2011 and January 2013 by a single surgeon were included. The data were
collected retrospectively and patient outcomes (GORD-HRQL quality of life
questionnaire) were obtained both pre and post-operatively.
Results: 23 patients with a median age of 63 years underwent the pro-
cedure, 14 of which received mesh augmentation. Comparable symptom-
atic improvement (GORD-HRQL) was seen in both groups. Three patients
(13%) complained of mild dysphagia (2 in the mesh group), one patient
from the mesh group had a minor surgical site infection and one patient
from each group had a post-operative pneumonia. No patient required a
re-operation for recurrence of symptoms.
Conclusions: Augmentation of the hiatal repair with biosynthetic mesh
may be necessary to achieve comparable postoperative outcomes in
selected cases with a large hiatus hernia. We suggest a randomised control
trial with long-term follow-up for deﬁnitive evaluation.
0187: AN AUDIT OF MANAGEMENT OF ACUTE PANCREATITIS IN A NET-
WORKED DISTRICT GENERAL HOSPITAL
Mohammed Elsayed *, James Pine, John Wayman, John Robinson.
Cumberland Inﬁrmary, Carlisle, UK.
Introduction: To re-audit the management of acute pancreatitis against
the UK Working Party on Acute Pancreatitis guidelines in a DGH after
introduction of tertiary centre networking.
Methods: A northern regional audit was performed in 2007. Following the
introduction of networking with the tertiary centre a re-audit wasundertaken on consecutive patients admitted with acute pancreatitis,
between May 2012 and March 2013.
Results: 33 patients were identiﬁed. Aetiology was determined in 75.8%
(Target 80%, previously 88.0%). Diagnosis was achieved within 48 hours
in all patients and severity stratiﬁcation in 66.7% (Target 100%, previ-
ously 17.6%). Imaging within 24 hours was performed in 75.8% (Target is
100%, previously 26.9%). Overall survival rate was 96.5% (Target 90%,
previously 94.4%). In severe cases 42.9% were admitted to high de-
pendency unit (Target 100%, previously 24.3%). 75.0% had computer
tomography after seven or more days of admission (Target 100%, pre-
viously 81.8%). 60.0% of patients with severe gallstone pancreatitis had
an urgent endoscopic retrograde cholangiopancreatography (Target
100%, previously 20.0%). Survival in severe cases was 85.7% (Target 70%,
previously 83.3%).
Conclusions: There is an improvement in adherence to national guidelines
and patient outcome since the initial regional audit and greater collabo-
rative working between secondary and tertiary units.
0191: VENOUS THROMBOEMBOLISM RISK IN GASTRIC CANCER PA-
TIENTS
Ruth Graham *, Joy Singh. Glangwili General Hospital, Carmarthen, UK.
Introduction: To show patients with Gastric cancer have an increased risk
of VTE and that this risk increases further with chemotherapy.
Methods: CANISCC database was used to identify patients diagnosed with
Gastric Cancer from 2008-2012. Clinical portal allowed identiﬁcation of
patients who had follow-up CT scans and those who were diagnosed with
Pulmonary Embolism (PE) or Deep vein thrombosis (DVT). The Health
Board chemotherapy database was used to identify treatment regimes.
Results: Of the 157 patients identiﬁed, 103 went on to have treatment and
62 had follow-up CT scans. 53 patients had chemotherapy,15 in association
with surgery and 3 with endoscopic treatment. 31 patients had surgery
and 19 endoscopic treatment only. A total of 5 PEs and 8 DVTs were
identiﬁed. PEs were noted in patients who had surgery and chemotherapy
(3,20%) and chemotherapy alone (2, 7.7%). DVTs were identiﬁed in patients
who had no treatment (2, 3.7%), chemotherapy alone (2, 5.7%) and surgery
alone (4, 12.9%).
Conclusions: Patients with Gastric Cancer have a higher risk of PE/DVT
than the general population. Our results suggest around 1/5 patients who
have surgery and chemotherapy will have a PE. We recommend VTE
prophylaxis during treatment.
0194: BARIATRIC SURGERY PRODUCES SIGNIFICANT AND SUSTAINED
REDUCTION IN POLYPHARMACY DEPENDENCY IN OBESE PATIENTS e
A RETROSPECTIVE REVIEW OF POST-OPERATIVE OUTCOMES IN NHS
LOTHIAN
Stefanie Chua *,1, Laura Arthur 1, Andrew de Beaux 2, Bruce Tulloh 2,
Peter Lamb 2. 1University of Edinburgh, UK; 2Department of General and
Upper GI surgery, Royal Inﬁrmary of Edinburgh, UK.
Introduction: To evaluate medication dependency, prescription costs,
weight and BMI for patients pre- and post-bariatric surgery in NHS Lothian.
Methods: 140 patients who underwent 162 procedures from November
2003 - March 2012 were identiﬁed from a prospectively maintained
departmental database. Data was collated from case notes and electronic
records review. Weight, height and prescription drugs pre- and post-
operatively at yearly intervals were recorded where available up to 4 years
post-surgery. Drug pricing was sourced fromwww.bnf.org. Follow-up data
was complete for 54 patients who were included in this analysis. Paired t-
tests were calculated in SPSS v.19 with signiﬁcance set at p<0.05.
Results: The number of obesity-related drugs taken daily decreased signiﬁ-
cantly at 1-year post-surgery from 3.3±2.6 to 1.6±1.8; p<0.000. This reduc-
tion in medication use was sustained at yearly intervals until 4 years post-
surgery. Therewas signiﬁcant reduction in drug costs pre-operatively; mean
£541.94, and 1-year post-operatively;mean £234.75, p¼0.002. Reduced drug
costs were sustained at yearly intervals up to 4 years. Weight decreased
signiﬁcantly: pre-operative mean 140.78kg, 1-year post-operative mean
106.55kg, p¼0.000.Weight loss was signiﬁcant and sustained across 4 years.
Conclusions: Bariatric surgery produced signiﬁcant weight loss with
associated sustained reduction in obesity-related medication dependency
and cost.
